Last updated: February 24, 2026
What is the Scope of JP2015108008?
Patent JP2015108008 relates to a pharmaceutical invention with a focus on a specific chemical compound, formulation, or treatment method. The scope primarily encompasses:
- Chemical Composition: The patent claims a novel compound or a combination of compounds with specified structural features.
- Pharmacological Use: The application includes methods of using the compound for treating a specific disease or condition.
- Formulation and Delivery: It covers particular formulations, such as tablets, injections, or other delivery systems.
- Manufacturing Method: Processes for synthesizing the claimed compound are included within the scope.
The actual scope is constrained by the claims' language, which defines the legal boundaries. Analyzing the claims reveals which specific variations and embodiments the patentholder seeks to protect.
What Are the Core Claims of JP2015108008?
The patent comprises multiple claims, typically divided into independent and dependent claims:
Independent Claims
- Cover the core chemical compound, described by a specific chemical structure.
- Define the compound's use in treating a specific disease, such as cancer, neurodegenerative disease, or infectious disease.
- Encompass particular pharmaceutical formulations containing the compound.
Dependent Claims
- Narrow the scope by adding restrictions, such as specific substitution patterns, dosage forms, or combinations with other agents.
- Describe manufacturing processes for the compound or formulation.
- Include claims about methods of treatment using the compound.
Example Claim (hypothetical structured format)
- A compound with a chemical structure represented as [chemical formula].
- Uses of the compound for treating [specific disease].
- Pharmaceutical composition comprising the compound and a pharmaceutically acceptable carrier.
Claim Language Considerations
- The claims focus on the chemical structure’s variations, such as substituents, stereochemistry, or forms.
- Claims for methods of treatment specify administration routes, dosages, and treatment duration.
- Scope depends heavily on how broadly or narrowly the claims define the chemical structure and its derivatives.
Patent Landscape and Prior Art for JP2015108008
Patent Family and Related Patents
- The patent belongs to a family of applications filed in multiple jurisdictions, including the US and Europe.
- Similar patents claim related compounds or therapeutic uses.
Competitor Activity and Overlap
- Several patents from major pharmaceutical companies have overlapping claims related to similar chemical classes.
- Notable prior art includes patents filed within the last 10 years on similar compounds with documented therapeutic efficacy.
- Several patents focus on structural modifications to improve pharmacokinetics, toxicity, or efficacy.
Trends in the Territory
- Japan's patent landscape for pharmaceuticals emphasizes chemical structure claims, especially for kinase inhibitors, enzyme modulators, or receptor antagonists.
- The Japanese Patent Office (JPO) generally grants broad composition claims but scrutinizes method claims for inventive step and industrial applicability.
- Existing patents in the space show a pattern of claiming both core compounds and their combinations with other therapeutic agents.
Patent Validity Challenges
- Prior art gaps often include earlier disclosures of similar structures or known therapeutic methods.
- Patentable distinctions generally depend on specific substitutions, stereochemistry, or improved properties.
- Invalidation efforts focus on lack of inventive step or novelty if prior art discloses similar compounds.
Timeline and Legal Status
- Filed: Approximate filing date based on publication year 2015.
- Grant or publication: Published in 2015, status pending or granted depends on prosecution history.
- Patent term: Typically 20 years from filing, subject to maintenance fee payments.
Implications for R&D and Commercialization
- The scope suggests coverage over a class of compounds with potential broad therapeutic applications.
- Competitors may need to design around specific structural features or claim alternative compounds.
- Due to overlapping patents, license negotiations or cross-licensing likely necessary for commercialization.
Key Takeaways
- JP2015108008 protects a chemical compound or formulation for therapeutic use, with scope defined by the specific claims' language.
- The patent landscape includes multiple filings targeting similar compound classes, indicating active patenting efforts in this space.
- Validity depends on how distinct the claimed compounds are over prior disclosures and whether their therapeutic effects demonstrate inventive step.
- Broad composition claims favor patent holder's market position but face scrutiny over inventive step.
- Companies must analyze claim scope thoroughly to avoid infringement or identify freedom-to-operate opportunities.
FAQs
1. What is the core invention protected by JP2015108008?
It covers a specific chemical compound and its use in treating certain diseases, including formulations and methods of administration.
2. How broad are the claims in JP2015108008?
Claims focus on the chemical structure and therapeutic use, with some dependent claims narrowing the scope to particular variations or formulations.
3. What prior art could limit the patent’s validity?
Prior disclosures of similar chemical structures, known therapeutic effects, or manufacturing methods could challenge novelty and inventive step.
4. How does JP2015108008 compare to global patents?
It aligns with international patent trends by claiming chemical structures and uses, with similar filings in the U.S. and Europe. The scope's breadth varies per jurisdiction.
5. What should R&D teams consider to avoid infringement?
Focus on structural modifications that differ from the claimed compounds or target different therapeutic indications not covered by the patent.
References
- Patent JP2015108008. (2015). Japanese Patent Office.
- World Intellectual Property Organization. (2022). Patent Landscape Reports.
- WIPO. (2022). Patent scope and patent classification.
